Hamps Bio Limited (BOM:544312)
India · Delayed Price · Currency is INR 18.50
+0.50 (2.78%)
At close: Feb 12, 2026
Hamps Bio Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 71.2 | 66.69 | 64.75 | 55.78 | 53.41 | 38.22 |
Other Revenue | - | - | - | - | -0 | - |
| 71.2 | 66.69 | 64.75 | 55.78 | 53.4 | 38.22 | |
Revenue Growth (YoY) | - | 2.99% | 16.08% | 4.45% | 39.71% | -17.67% |
Cost of Revenue | 25.48 | 21.27 | 18.1 | 19.05 | 22.71 | 18.7 |
Gross Profit | 45.72 | 45.41 | 46.66 | 36.73 | 30.69 | 19.53 |
Selling, General & Admin | 24.66 | 23.27 | 21.22 | 18.06 | 16.99 | 12.97 |
Other Operating Expenses | 16.8 | 14.25 | 13.52 | 10.01 | 7.55 | 4.57 |
Operating Expenses | 46.36 | 41.29 | 38.77 | 31.46 | 27.79 | 20.83 |
Operating Income | -0.63 | 4.13 | 7.88 | 5.28 | 2.9 | -1.3 |
Interest Expense | -1.44 | -1.11 | -1.43 | -1.71 | -1.87 | -2.56 |
Interest & Investment Income | 1.27 | 1.27 | 0.07 | 0.03 | 0.03 | 0 |
Currency Exchange Gain (Loss) | 0.04 | 0.04 | - | - | - | - |
Other Non Operating Income (Expenses) | -0.75 | -0.29 | -0.02 | -0.07 | -0.03 | -0.03 |
EBT Excluding Unusual Items | -1.51 | 4.04 | 6.5 | 3.53 | 1.04 | -3.89 |
Gain (Loss) on Sale of Investments | - | - | - | 0.01 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0 |
Other Unusual Items | - | - | - | 0.03 | 0.01 | - |
Pretax Income | -1.51 | 4.04 | 6.5 | 3.57 | 1.05 | -2.22 |
Income Tax Expense | 0.12 | 1.06 | 1.49 | -0.02 | -0.17 | 0.02 |
Net Income | -1.63 | 2.98 | 5.01 | 3.59 | 1.22 | -2.24 |
Net Income to Common | -1.63 | 2.98 | 5.01 | 3.59 | 1.22 | -2.24 |
Net Income Growth | - | -40.53% | 39.44% | 195.47% | - | - |
Shares Outstanding (Basic) | 12 | 9 | 4 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 12 | 9 | 4 | 5 | 5 | 5 |
Shares Change (YoY) | 272.03% | 122.25% | -26.76% | - | 11.50% | 50.00% |
EPS (Basic) | -0.14 | 0.34 | 1.28 | 0.67 | 0.23 | -0.47 |
EPS (Diluted) | -0.14 | 0.34 | 1.27 | 0.67 | 0.23 | -0.47 |
EPS Growth | - | -73.33% | 90.30% | 197.78% | - | - |
Free Cash Flow | - | -54.88 | -6.54 | 4 | 0.42 | - |
Free Cash Flow Per Share | - | -6.30 | -1.67 | 0.75 | 0.08 | - |
Gross Margin | 64.22% | 68.10% | 72.05% | 65.85% | 57.48% | 51.09% |
Operating Margin | -0.89% | 6.19% | 12.17% | 9.46% | 5.43% | -3.40% |
Profit Margin | -2.29% | 4.46% | 7.73% | 6.44% | 2.27% | -5.85% |
Free Cash Flow Margin | - | -82.29% | -10.09% | 7.18% | 0.78% | - |
EBITDA | 4.13 | 7.89 | 11.92 | 8.66 | 6.15 | 1.98 |
EBITDA Margin | 5.80% | 11.83% | 18.41% | 15.53% | 11.52% | 5.19% |
D&A For EBITDA | 4.76 | 3.76 | 4.04 | 3.39 | 3.25 | 3.28 |
EBIT | -0.63 | 4.13 | 7.88 | 5.28 | 2.9 | -1.3 |
EBIT Margin | -0.89% | 6.19% | 12.17% | 9.46% | 5.43% | -3.40% |
Effective Tax Rate | - | 26.27% | 22.97% | - | - | - |
Revenue as Reported | 72.25 | 68.2 | 65.01 | 55.85 | 53.45 | 39.9 |
Advertising Expenses | - | - | 0.66 | - | - | 0.11 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.